MedTrace Logo

Effect of Virtual Reality on Prostaglandin Levels in Adolescent Females With Primary Dysmenorrhea

NCT06987838 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-05-23

No results posted yet for this study

Summary

This study will be conducted to study the effect of virtual reality therapy on prostaglandin levels in adolescent females with primary dysmenorrhea.

Conditions

  • Primary Dysmenorrhea

Interventions

DRUG

Pharmacological treatment

All participants in the two groups will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles.

OTHER

Virtual reality

The experimental group will receive virtual reality during the first 2 days of menstruation, for 3 menstrual cycles.

Sponsors & Collaborators

  • Benha National University

    lead OTHER

Principal Investigators

  • Sally Mohamed Saeed, PhD · Lecturer, Benha National University

  • Malak Adel El Mahdy, PhD · Lecturer, Al Hayah University

  • Sarah Abdullah Mohamed Elsamahy, PhD, PhD · Lecturer, Misr University for Science and Technology

  • Samah Mahmoud Ahmed sheha, PhD · Lecturer, Misr University for Science and Technology

  • Naglaa fathey moustafa, PhD · Lecturer, Al Hayah University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-25
Primary Completion
2025-08-25
Completion
2025-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06987838 on ClinicalTrials.gov